Loading clinical trials...
Loading clinical trials...
Clinical Study to Evaluate the Efficacy and Safety of the Combination Therapy Candesartan Cilexetil 32 mg Plus Hydrochlorothiazide 25 mg in Patients With Severe Hypertension
Conditions
Interventions
Candesartan cilexetil and hydrochlorothiazide
Locations
16
Germany
Berlin, Germany
Blankenhain, Germany
Dortmund, Germany
Hamburg, Germany
Köthen, Germany
Löhne, Germany
Start Date
October 1, 2009
Primary Completion Date
May 1, 2010
Completion Date
June 1, 2010
Last Updated
July 14, 2010
NCT02417740
NCT07073820
NCT07480265
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Takeda
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions